Home > Insider Trading > Filing (0000919574-21-003214)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1533743	Processa Pharmaceuticals Inc.	PCSA	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1512127	E James Besser	53 Palmeras Street Caribe Plaza Building 6Th Floor San Juan PR 00901		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	Disposition	2021-02-18	5,000	$11.35	1,120,000	No	4	S	Indirect	See footnotes
Common Stock, $0.01 Par Value	Disposition	2021-02-19	3,000	$11.20	1,117,000	No	4	S	Indirect	See footnotes
Common Stock, $0.01 Par Value	Disposition	2021-02-22	20,929	$11.56	1,096,071	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	405,000	Direct

Footnotes

These securities are directly owned by Manchester Explorer, L.P. and JEB Partners, L.P. These securities are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P.; these securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC.
The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.